MediWound Ltd. MDWD
13.39 USD -0.11 (-0.81%)
At closeNov 4, 2026, 8:42 AM EST
13.10 -0.29 -2.17%
Pre-market · Nov 4, 8:42 AM ET
13.33 Day range 13.81
11.80 52-week range 19.70
- YTD
- -27.46%
- 1 year
- -25.20%
Analyst view
Price target (mean) 29.00 +116.6% upside
Now 13.39
- Target (low)
- 25.00
- Target (mean)
- 29.00
- Target (high)
- 36.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy2
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.55667 | -0.63 – -0.50 | -0.19 | -193.0% | 5.83M | +9.3% | 3 |
| Next quarter | -0.555 | -0.56 – -0.55 | -1.05 | +47.1% | 5.60M | +12.9% | 2 |
| Current year | -3.26 | -3.33 – -3.19 | -0.75 | -335.1% | 20.22M | +8.2% | 3 |
| Next year | -2.31 | -2.69 – -1.83 | -3.26 | +29.2% | 25.55M | +26.4% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 27, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 30, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 16, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 22, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 21, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 17, 2023 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 17, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 31, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| May 31, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 17, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Jan 4, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Dec 30, 2022 | Cowen & Co. | Maintained | — | Outperform |
| Dec 22, 2022 | Maxim Group | Initiated | — | Buy |
| Dec 21, 2022 | Oppenheimer | Maintained | — | Outperform |
| Nov 16, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| May 18, 2022 | Wells Fargo | Maintained | — | Overweight |
| Mar 21, 2022 | Aegis Capital | Maintained | — | Buy |
| Aug 17, 2021 | Aegis Capital | Maintained | — | Buy |
| Aug 11, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 2, 2021 | Aegis Capital | Initiated | — | Buy |
| Sep 23, 2020 | BTIG | Initiated | — | Buy |
| Aug 5, 2019 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 20, 2018 | Wells Fargo | Maintained | Outperform | Outperform |
| Mar 20, 2018 | Oppenheimer | Maintained | Outperform | Outperform |
| Sep 28, 2017 | Cowen & Co. | Initiated | — | Outperform |
| Nov 28, 2016 | Aegis Capital | Initiated | — | Buy |